genedrive plc (LON:GDR – Get Free Report) shares traded up 0.2% during mid-day trading on Thursday . The company traded as high as GBX 1.10 and last traded at GBX 1.03. 3,438,420 shares were traded during mid-day trading, a decline of 49% from the average session volume of 6,745,752 shares. The stock had previously closed at GBX 1.03.
genedrive Stock Performance
The company has a market capitalization of £10.57 million, a price-to-earnings ratio of -1.14 and a beta of -0.04. The company has a debt-to-equity ratio of 0.35, a current ratio of 4.60 and a quick ratio of 5.52. The stock has a 50 day moving average price of GBX 0.96 and a two-hundred day moving average price of GBX 0.81.
genedrive Company Profile
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
Featured Stories
- Five stocks we like better than genedrive
- The day the gold market broke
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Trump Planning to Use Public Law 63-43: Prepare Now
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
